However, it's crucial to understand the current state of research and clinical evidence
This is becoming an important supplement for people who are rapidly losing weight on GLP-1 medications and losing muscle mass as well as fat
These studies have led to the advancement of pan and isoform selective HDAC inhibitors as potential therapeutic agents for treatment of AD (Yang et al., 2017)

Three things make PDRN a strong alternative for users disappointed by copper peptides: It signals regeneration through a different pathway, so it does not produce the same inflammatory adjustment phase that drives the copper uglies It has fewer documented interactions with other actives, which makes it easier to fit into an existing routine It is generally well tolerated even by sensitive skin, and pregnancy precautions are less restrictive (though pregnant or breastfeeding users should still consult a doctor before adding any new active) The people who tend to do well on PDRN after a bad copper peptide experience usually fit one of three profiles: sensitive-skin users who could never tolerate the copper uglies, users who want regenerative benefits without managing strict layering rules, and users whose primary concern is repair and resilience rather than aggressive remodelling
Peptide therapy often produces the best results as part of a broader optimization protocol
If you couldn't tolerate GHK-CU, retinoids might work well, though they have their own adjustment period